Error: Could not add to watchlist. X

BB Adamant Global Biotech

+ Watchlist
ADGLBII:SW
3,800.24
CHF
1.40
0.04%
As of 11:12:00 ET on 07/02/2015.
Volume
0
Previous Close
3,798.84
52Wk Range
2,494.14 - 4,120.93
1 Yr Return
39.15%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
3,800.24
Total Assets (m CHF) (on 07/02/2015)
164.580
Inception Date
10/15/2010
Last Dividend (on 12/05/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.24%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 130.00 k 14.98 m 9.17
Biogen Inc 37.00 k 14.37 m 8.79
Amgen Inc 95.00 k 14.20 m 8.69
Gilead Sciences Inc 130.00 k 12.76 m 7.81
Alexion Pharmaceuticals Inc 52.00 k 8.89 m 5.44
Vertex Pharmaceuticals Inc 73.00 k 8.27 m 5.06
Regeneron Pharmaceuticals Inc 21.00 k 8.24 m 5.04
Illumina Inc 40.00 k 7.41 m 4.54
Medivation Inc 65.00 k 7.24 m 4.43
Isis Pharmaceuticals Inc 110.00 k 7.15 m 4.37
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050